Recently, antagonists of the kappa opioid receptor (KOR) have attracted significant attention due to their potential use in treating various central nervous system (CNS) disorders, especially mood disorders and substance abuse [1,2,3,4,5]. The gene discussed is OPRK1; the disease is substance abuse.